Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir for suppression of recurrent ano-genital HSV in HIV-infected subjects
NCT00005663Phase 3Unknown
- Sponsor
- GSK
- Start
- Jun 1999
- Modality
- Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of valaciclovir in genital herpes, sponsored by GSK. Status: unknown.
02
Drugs
valaciclovir
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT00005663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005663.